Formulation and in vitro characterization of poly(dl-lactide-co-glycolide)/Eudragit RLPO or RS30D nanoparticles as an oral carrier of levofloxacin hemihydrate

References

• Diren S, Zeynep FK. Bioavailability file: levofloxacin. J Pharm Sci 2007;32:197–208
   Google Scholar
• Foged C, Brodin B, Frokjaer S, et al. Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model. Int J Pharm 2005;298:315–322
   PubMed Web of Science ®Google Scholar
• Vasir JK, Labhasetwar V. Quantification of the force of nanoparticle–cell membrane interactions and its influence on intracellular trafficking of nanoparticles. Biomaterials 2008;29:4244–4252
   PubMed Web of Science ®Google Scholar
• Yue ZG, Wei W, LV PP, et al. Surface charge affects cellular uptake and intracellular trafficking of chitosan-based nanoparticles. Biomacromolecules 2011;12:2440–2446
   PubMed Web of Science ®Google Scholar
• Cheow WS, Hadinoto K. Enhancing encapsulation efficiency of highly water-soluble antibiotic in poly(lactic-co-glycolic acid) nanoparticles: modifications of standard nanoparticle preparation methods. Colloids Surf A 2010;370:79–86
   Web of Science ®Google Scholar
• Kumar G, Sharma S, Shafiq N, et al. Optimization, in vitro in vivo evaluation, and short-term tolerability of novel levofloxacin-loaded PLGA nanoparticle formulation. J Pharm Sci 2012;101:2165–2176
   PubMed Web of Science ®Google Scholar
• Montanari E, D’Arrigo G, Di Meo C, et al. Chasing bacteria within the cells using levofloxacin-loaded hyaluronic acid nanohydrogels. Eur J Pharm Biopharm 2014;87:518–523
   PubMed Web of Science ®Google Scholar
• Guan J, Cheng P, Huang SJ, et al. Optimized preparation of levofloxacin-loaded chitosan nanoparticles by ionotropic gelatin. Phys Procedia 2011;22:163–169
   Google Scholar
• Mohamed F, Van der Walle CF. Engineering biodegradable polyester particles with specific drug targeting and drug release properties. J Pharm Sci 2008;97:71–187
   PubMed Web of Science ®Google Scholar
• Danhier F, Feron O, Preat V. To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J Control Release 2010;148:135–146
   PubMed Web of Science ®Google Scholar
• Tahara K, Sakai T, Yamamoto H, et al. Improved cellular uptake of chitosan-modified PLGA nanospheres by A549 cells. Int J Pharm 2009;382:198–204
   PubMed Web of Science ®Google Scholar
• Hoffart V, Ubrich N, Simonin C, et al. Low molecular weight heparin loaded polymeric nanoparticles: formulation, characterisation, and release characteristics. Drug Dev Ind Pharm 2002;28:1091–1099
   PubMed Web of Science ®Google Scholar
• Cetin M, Atila A, Kadioglu Y. Formulation and in vitro characterization of Eudragit® L100 and Eudragit® L100-PLGA nanoparticles containing diclofenac sodium. AAPS PharmSciTech 2010;11:1250–1256
   PubMed Web of Science ®Google Scholar
• Cetin M, Aktas MS, Vural I, et al. Salmon calcitonin-loaded Eudragit® and Eudragit®-PLGA nanoparticles: in vitro and in vivo evaluation. J Microencapsul 2012;29:156–166
   PubMed Web of Science ®Google Scholar
• Dillen K, Vandervoort J, Van den Mooter G, et al. Evaluation of ciprofloxacin-loaded Eudragit® RS100 or RL100/PLGA nanoparticles. Int J Pharm 2006;314:72–82
   PubMed Web of Science ®Google Scholar
• Omari DM, Sallam A, Abd-Elbary A, et al. Lactic acid-induced modifications in films of Eudragit RL and RS aqueous dispersions. Int J Pharm 2004;274:85–96
   PubMed Web of Science ®Google Scholar
• Alkhatib HS, Sakr A. Optimization of methacrylic acid ester copolymer blends as controlled release coating using response surface methodology. Pharm Dev Technol 2003;8:87–96
   PubMed Web of Science ®Google Scholar
• Muthu MS, Rawat MK, Mishra A, et al. PLGA nanoparticle formulations of risperidone: preparation and neuropharmacological evaluation. Nanomedicine 2009;5:323–333
   PubMed Web of Science ®Google Scholar
• Gupta H, Aqil M, Khar RK, et al. Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug delivery. Nanomedicine Nanotechnol Biol Med 2010;6:324–333
   PubMed Web of Science ®Google Scholar
• Pignatello R, Bucolo C, Ferrara P, et al. Eudragit RS100 nanosuspensions for the ophthalmic controlled delivery of ibuprofen. Eur J Pharm Sci 2002;16:53–61
   PubMed Web of Science ®Google Scholar
• Kompella U, Bandi N, Ayalasomayajula S. Poly (lactic acid) nanoparticles for sustained release of budesonide. Drug Deliv Technol 2001;1:29–35
   Google Scholar
• Pignatello R, Bucolo C, Spedalieri G, et al. Flurbiprofenloaded acrylate polymer nanosuspensions for ophthalmic application. Biomaterials 2002;23:3247–3255
   PubMed Web of Science ®Google Scholar
• Tiefenbacher EM, Haen E, Przybilla B, et al. Photodegradation of some quinolones used as antimicrobial therapeutics. J Pharm Sci 1994;83:463–467
   PubMed Web of Science ®Google Scholar
• National Committee for Clinical Laboratory Standards Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically. 4th ed. Wayne, PA: Approved Standard NCCLS Document M7-A4; 1997
   Google Scholar
• Haznedar S, Dortunc B. Preparation and in vitro evaluation of Eudragit microspheres containing acetazolamide. Int J Pharm 2004;269:131–140
   PubMed Web of Science ®Google Scholar
• Galindo-Rodriguez S, All'emann E, Fessi H, et al. Physicochemical parameters associated with nanoparticle formation in the salting out, emulsification-diffusion, and nanoprecipitation methods. Pharm Res 2004;21:1428–1439
   PubMed Web of Science ®Google Scholar
• Zhang L, Chan JM, Gu FX, et al. Self-assembled lipid–polymer hybrid nanoparticles: a robust drug delivery platform. ACS Nano 2008;2:1696–702
   PubMed Web of Science ®Google Scholar
• Hu Y, Ehrich M, Fuhrman K, et al. In vitro performance of lipid-PLGA hybrid nanoparticles as an antigen delivery system: lipid composition matters. Nanoscale Res Lett 2014;9:434–443
   PubMed Web of Science ®Google Scholar
• Fattal E, Quaglia F, Gupta P, et al. Biodegradable microparticles for the development of less-painful and less-irritating parenterals. In: Gupta P, Brazeau G, eds. Injectable drug development: techniques to reduce pain and irritation. London: Informa Health Care 1999:355–378
   Google Scholar
• Baby B, Harsha NS, Jayaveera KN, et al. Formulation and evaluation of levofloxacin nanoparticles by ionic gelation method. Res Rev J Pharm Pharm Sci 2012;1:7–15
   Google Scholar
• Kharia AA, Singhai AK, Verma R. Formulation and evaluation of polymeric nanoparticles of an antiviral drug for gastroretention. Int J Pharm Sci Nanotechnol 2012;4:1557–1562
   Google Scholar
• Jiao Y, Ubrich N, Hoffart V, et al. Anticoagulant activity of heparin following oral administration of heparin-loaded microparticles in rabbits. J Pharm Sci 2002;91:760–768
   PubMed Web of Science ®Google Scholar
• Hasan AA. Formulation and evaluation of dorzolamide hydrochloride loaded nanoparticles as controlled release drug delivery system. Asian J Pharm 2012;6:67–73
   Google Scholar
• Romero-Cano M, Vinceent B. Controlled release of 4-nitroanisole from poly (lactic acid) nanoparticles. J Control Release 2002;82:127–135
   PubMed Web of Science ®Google Scholar
• Alvarez-Fuentes J, Fernández-Arévalo M, González-Rodríguez ML, et al. Development of enteric-coated timed-release matrix tablets for colon targeting. J Drug Target 2004;12:607–612
   PubMed Web of Science ®Google Scholar
• Puratchikody A, Prasanth VV, Sam TM, et al. Development and characterization of mucoadhesive patches of salbutamol sulphate for unidirectional buccal drug delivery. Acta Pharm 2011;61:157–170
   PubMed Web of Science ®Google Scholar
• Gevariya HB, Gami S, Patel N. Formulation and characterization of levofloxacin-loaded biodegradable nanoparticles. Asian J Pharm 2011;5:114–119
   Google Scholar
• Heurtault B, Saulnier P, Pech B, et al. Physicochemical stability of colloidal lipid particles. Biomaterials 2003;24:4283–4300
   PubMed Web of Science ®Google Scholar
• Mosqueira VC, Legrand P, Gref R, et al. In-vitro release kinetic studies of PEG-modified nanocapsules and nanospheres loaded with a lipophilic drug: halofantrine base. Proc Int Symp Control Rel Bioact Mater 1999;26:1074–1075
   Google Scholar
• Frohlich E. The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles. Int J Nanomedicine 2012;7:5577–5591
   PubMed Web of Science ®Google Scholar
• Dillen K, Bridts C, Van der Veken P, et al. Adhesion of PLGA or Eudragit/PLGA nanoparticles to Staphylococcus and Pseudomonas. Int J Pharm 2008;349:234–240
   PubMed Web of Science ®Google Scholar
• Chung YC, Wang HL, Chen YM, et al. Effect of abiotic factors on the antibacterial activity of chitosan against waterborne pathogens. Bioresour Technol 2003;88:179–184
   PubMed Web of Science ®Google Scholar
• Hancock RE. Peptide antibiotics. Lancet 1997;349:418–422
   PubMed Web of Science ®Google Scholar
• Liu L, Xu K, Wang H, et al. Self-assembled cationic peptide nanoparticles as an efficient antimicrobial agent. Nat Nanotechnol 2009;4:457–463
   PubMed Web of Science ®Google Scholar